Skip to main content

Table 6 Effect of treatment groups on quality of life score

From: Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction

Visit Chitosan
(mean ± SD) [range]
Placebo
(mean ± SD) [range]
P value
PCS Score
Day 0 (n = 58, 31) 40.99 ± 6.51 [22.80 − 56.90] 41.26 ± 5.78 [33.10 − 57.70] 0.869
Day 90 (n = 59, 31) 51.32 ± 7.23*@ [32.10 − 61.80] 43.19 ± 7.50[31.20 − 56.40] < 0.0001
Change from baseline (PCS Score)
Day 90 (n = 59, 31) 10.58 ± 8.07@ [-27.70 – 8.50] 1.93 ± 5.69 [−17.60 – 6.30] < 0.0001
MCS score
Day 0 (n = 58, 31) 48.34 ± 6.77 [27.20 − 60.50] 46.16 ± 7.77 [17.70 − 61.90] 0.173
Day 90 (n = 59, 31) 49.10 ± 7.08 [33.20 − 61.60] 47.45 ± 6.60 [27.90 − 62.40] 0.283
Change from baseline (MCS Score)
Day 90 (n = 59, 31) 0.98 ± 6.73 [-20.80 − 16.70] 1.28 ± 8.81 [-34.30 − 10.60] 0.4755
  1. Values are expressed as Mean ± Standard deviation (SD). * = statistically significant as compared to baseline. @ - statistically significant as compared to placebo at day 90. N = Number of subjects in each treatment group